BCL2 Is a Downstream Effector of MIZ-1 Essential for Blocking c-MYC-induced Apoptosis*
暂无分享,去创建一个
[1] S. McMahon,et al. Targeting of Miz-1 Is Essential for Myc-mediated Apoptosis* , 2006, Journal of Biological Chemistry.
[2] E. Wieschaus,et al. Polycomb mediates Myc autorepression and its transcriptional control of many loci in Drosophila. , 2005, Genes & development.
[3] Stephen W. Fesik,et al. Promoting apoptosis as a strategy for cancer drug discovery , 2005, Nature Reviews Cancer.
[4] S. McMahon,et al. Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[5] C. Croce,et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Lowe,et al. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants , 2005, Nature.
[7] R. Gascoyne,et al. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2‐positive germinal center B‐cell lymphomas , 2005, Genes, chromosomes & cancer.
[8] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[9] S. Korsmeyer,et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.
[10] S. Mukhopadhyay,et al. Transformation of follicular lymphoma to Burkitt-like lymphoma within a single lymph node. , 2005, Human pathology.
[11] M. Eilers,et al. Pontin and Reptin regulate cell proliferation in early Xenopus embryos in collaboration with c-Myc and Miz-1 , 2005, Mechanisms of Development.
[12] D. Matallanas,et al. Myc Antagonizes Ras-mediated Growth Arrest in Leukemia Cells through the Inhibition of the Ras-ERK-p21Cip1 Pathway* , 2005, Journal of Biological Chemistry.
[13] C. Barton,et al. Transcriptional control of Nramp1: a paradigm for the repressive action of c-Myc. , 2004, Biochemical Society transactions.
[14] S. Korsmeyer,et al. Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix , 2004, Science.
[15] S. Korsmeyer,et al. Antiapoptotic BCL-2 is required for maintenance of a model leukemia. , 2004, Cancer cell.
[16] A. Ozdek,et al. C-Myc And Bcl-2 Expression In Supraglottic Squamous Cell Carcinoma of the Larynx , 2004, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[17] S. McMahon,et al. Analysis of genomic targets reveals complex functions of MYC , 2004, Nature Reviews Cancer.
[18] E. Koonin,et al. Regeneration of Peroxiredoxins by p53-Regulated Sestrins, Homologs of Bacterial AhpD , 2004, Science.
[19] L. Penn,et al. c-Myc represses the proximal promoters of GADD45a and GADD153 by a post-RNA polymerase II recruitment mechanism , 2004, Oncogene.
[20] P. Bouillet,et al. Bim is a suppressor of Myc-induced mouse B cell leukemia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[21] L. Kretzner,et al. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product , 2004, Oncogene.
[22] R. Tjian,et al. Myc-interacting protein 1 target gene profile: a link to microtubules, extracellular signal-regulated kinase, and cell growth. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] John L Cleveland,et al. Myc pathways provoking cell suicide and cancer , 2003, Oncogene.
[24] J. Cleveland,et al. c-Myc Augments Gamma Irradiation-Induced Apoptosis by Suppressing Bcl-XL , 2003, Molecular and Cellular Biology.
[25] J. Cleveland,et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. , 2003, Cancer cell.
[26] F. Watt,et al. Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment , 2003, Development.
[27] A. D. Buss,et al. Identification of Chelerythrine as an Inhibitor of BclXL Function* , 2003, Journal of Biological Chemistry.
[28] Andrea Cocito,et al. Genomic targets of the human c-Myc protein. , 2003, Genes & development.
[29] B. Lüscher,et al. Stimulation of c‐MYC transcriptional activity and acetylation by recruitment of the cofactor CBP , 2003, EMBO reports.
[30] S. Kim,et al. Skp2 regulates Myc protein stability and activity. , 2003, Molecular cell.
[31] M. Eilers,et al. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter , 2003, Oncogene.
[32] Stella Pelengaris,et al. c-MYC: more than just a matter of life and death , 2002, Nature Reviews Cancer.
[33] John L Cleveland,et al. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. , 2002, Genes & development.
[34] S. Cory,et al. The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.
[35] M. Eilers,et al. Negative regulation of the mammalian UV response by Myc through association with Miz-1. , 2002, Molecular cell.
[36] A. Gartel,et al. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. , 2002, Molecular cancer therapeutics.
[37] C. Albanese,et al. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. , 2002, Molecular cell.
[38] J. Cleveland,et al. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1 , 2001, Oncogene.
[39] H. Nakayama,et al. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. , 2001, Molecular cell.
[40] S. Korsmeyer,et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. , 2001, Molecular cell.
[41] M. Roussel,et al. Apoptosis Triggered by Myc-Induced Suppression of Bcl-XL or Bcl-2 Is Bypassed during Lymphomagenesis , 2001, Molecular and Cellular Biology.
[42] R. Hehlmann,et al. bcl‐2 expression in non‐Hodgkin's lymphomas is not associated with bcl‐2 gene rearrangements , 2001, British journal of haematology.
[43] A. Strasser,et al. BH3-Only Proteins—Essential Initiators of Apoptotic Cell Death , 2000, Cell.
[44] N. Lee,et al. Identification of c-myc responsive genes using rat cDNA microarray. , 2000, Cancer research.
[45] E. Kandel,et al. Induction of Cell Cycle Progression and Acceleration of Apoptosis Are Two Separable Functions of c-Myc: Transrepression Correlates with Acceleration of Apoptosis , 2000, Molecular and Cellular Biology.
[46] Xiaodong Wang,et al. Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition , 2000, Cell.
[47] S. Srinivasula,et al. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[48] E. Lander,et al. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[49] U. Weidle,et al. Control of cell growth by c-Myc in the absence of cell division , 1999, Current Biology.
[50] G. Evan,et al. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. , 1999, Genes & development.
[51] E. Prochownik,et al. MYC oncogenes and human neoplastic disease , 1999, Oncogene.
[52] D. Felsher,et al. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[53] Ruedi Aebersold,et al. Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.
[54] M. Cole,et al. The Novel ATM-Related Protein TRRAP Is an Essential Cofactor for the c-Myc and E2F Oncoproteins , 1998, Cell.
[55] J L Cleveland,et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.
[56] G. Carmichael,et al. An alternative pathway for gene regulation by Myc , 1997, The EMBO journal.
[57] L. M. Facchini,et al. The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter , 1997, Molecular and cellular biology.
[58] G. Cesareni,et al. Analysis of the Myc and Max Interaction Specificity with λ Repressor-HLH Domain Fusions , 1995 .
[59] W. Kaelin,et al. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[60] V. S. Prasad,et al. Apoptosis and macrophage-mediated deletion of precursor B cells in the bone marrow of E mu-myc transgenic mice. , 1994, Blood.
[61] A. Levine,et al. p53 and E2F-1 cooperate to mediate apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[62] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[63] S. Lowe,et al. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. , 1993, Genes & development.
[64] N. Hay,et al. Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2 , 1993, Molecular and cellular biology.
[65] G. Evan,et al. Cooperative interaction between c-myc and bcl-2 proto-oncogenes , 1992, Nature.
[66] S. Korsmeyer,et al. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[67] D. Littman,et al. Packaging system for rapid production of murine leukemia virus vectors with variable tropism , 1992, Journal of virology.
[68] K. Kinzler,et al. Definition of a consensus binding site for p53 , 1992, Nature Genetics.
[69] J. Cleveland,et al. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.
[70] T. McDonnell,et al. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) , 1991, Nature.
[71] G. Inghirami,et al. Negative autoregulation of c‐myc gene expression is inactivated in transformed cells. , 1990, The EMBO journal.
[72] A. Strasser,et al. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 , 1990, Nature.
[73] G. Evan,et al. Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping , 1990, Molecular and cellular biology.
[74] L. Penn,et al. Negative autoregulation of c‐myc transcription. , 1990, The EMBO journal.
[75] S. Freytag. Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1 , 1988, Molecular and cellular biology.
[76] M. Cole,et al. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment , 1986, Nature.
[77] R. Palmiter,et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.
[78] D. Boettiger,et al. myc and src oncogenes have complementary effects on cell proliferation and expression of specific extracellular matrix components in definitive chondroblasts , 1985, Molecular and cellular biology.
[79] H. Lachman,et al. Expression of c-myc changes during differentiation of mouse erythroleukaemia cells , 1984, Nature.
[80] T. Graf,et al. Quail embryo fibroblasts transformed by four v‐myc‐containing virus isolates show enhanced proliferation but are non tumorigenic. , 1983, The EMBO journal.
[81] P. Pelicci,et al. "Myc represses transcription through recruitment of DNA methyltransferase corepressor" , 2005 .
[82] K. Berns,et al. Akt and 14-3-3η regulate Miz1 to control cell-cycle arrest after DNA damage , 2005, Nature Cell Biology.
[83] John D. Watson,et al. Promoter-binding and repression of PDGFRB by c-Myc are separable activities. , 2004, Nucleic acids research.
[84] R. Berger,et al. Presence of three recurrent chromosomal reaarrangements, t(2;3)(p12;q37), del(8)(q24), and t(14;18), in an acute lymphoblastic leukemia. , 1996, Cancer genetics and cytogenetics.
[85] C. Dang,et al. Max: functional domains and interaction with c-Myc. , 1992, Genes & development.
[86] J. Cleveland,et al. Negative regulation of c-myc transcription involves myc family proteins. , 1988, Oncogene research.
[87] K. Maruyama,et al. myc and E1A oncogenes alter the responses of PC12 cells to nerve growth factor and block differentiation. , 1987, Oncogene.